https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/accounts-receivable https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/accrued-marketing-costs-current https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/accrued-royalties-current https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/acquisition-contingent-consideration-liability-current https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/acquisition-contingent-consideration-liability-noncurrent https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/acquisitions https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/additional-paid-in-capital https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/adjustments-related-to-tax-withholding-for-share-based-compensation https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/advertising-expense https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/amortization https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/aoci https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/assets-noncurrent https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/basic-shares https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/business-acquisition-pro-forma-earnings-per-share-basic https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/business-acquisition-pro-forma-earnings-per-share-diluted https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/business-acquisitions-pro-forma-net-income-loss https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/business-acquisitions-pro-forma-revenue https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/cash-and-cash-equivalents-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/common-stock-no-par-value https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/common-stock-share-subscribed-but-unissued-subscriptions-receivable https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/comprehensive-income https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/contract-with-customer-performance-obligation-satisfied-in-previous-period https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/cost-of-goods-and-services-sold-amortization https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/cost-of-goods-sold-amortization https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/cost-of-goods-sold-excluding-depreciation-depletion-and-amortization https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/costs-and-expenses https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/deferred-income-tax-liabilities-net https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/deferred-revenue-recognized https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/deferred-tax-assets-gross-noncurrent https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/deferred-tax-assets-net-noncurrent https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance-noncurrent https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/deferred-tax-liabilities-gross-noncurrent https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/depreciation-amortization-and-accretion-net https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/depreciation-and-amortization https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/derivative-liabilities https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/dilutive-securities-effect-on-basic-earnings-per-share-other https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/eps https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/eps-basic https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/foreign-currency-transaction-gain-loss-unrealized https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/form-d-other https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/gain-loss-on-sale-of-investments https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/goodwill https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/goodwill-acquired https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/goodwill-foreign-currency-translation-gain-loss https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/goodwill-impaired-accumulated-impairment-loss https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/goodwill-translation-adjustments https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/income-taxes-paid https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/income-taxes-paid-2 https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/increase-decrease-in-employee-related-liabilities https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/increase-decrease-in-other-accrued-liabilities https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/increase-decrease-in-other-operating-capital-net https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/indefinite-lived-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/insider-transactions-warrants https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/interest-expense https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/interest-income-expense-nonoperating-net https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/interest-paid https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/interest-paid-net https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/interest-payable-current https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/inventory https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/inventory-finished-goods https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/inventory-gross https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/inventory-raw-materials-and-supplies https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/inventory-raw-materials-net-of-reserves https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/inventory-valuation-reserves https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/inventory-work-in-process https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/long-term-debt https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/long-term-purchase-commitment-amount https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/noncash-or-part-noncash-acquisition-fixed-assets-acquired https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/noncash-or-part-noncash-acquisition-intangible-assets-acquired https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/notes-payable https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/number-of-operating-segments https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/oci-net-of-tax https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/operating-lease-payments-due https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/other-current-liabilities https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/other-noncurrent-assets https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/other-sales-revenue-net https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/paid-in-capital-share-based-compensation-stock-options-requisite-service-period-recognition https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/payment-for-contingent-consideration-liability-operating-activities https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/payment-of-financing-and-stock-issuance-costs https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/payments-for-proceeds-from-other-investing-activities https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/preferred-stock-no-par-value https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/prepaid-expense-and-other-assets https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/pretax-income https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/profit-loss https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/revenue https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/sales-revenue-net https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/severance-costs https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/sga-expense https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/stock-award-number-of-additional-shares-authorized https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/stock-issued-shares-issued-for-acquisitions https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/tax-withholding-on-stock-awards https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/total-contract-liability https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/total-long-term-debt https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/valuation-allowances-and-reserves-adjustments https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/valuation-allowances-and-reserves-balance https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/valuation-allowances-and-reserves-charged-to-cost-and-expense https://stock.noler.com/us/stock/aralez-pharmaceuticals-inc/valuation-allowances-and-reserves-deductions